We investigated perceptions of wildlife policy and issues through questionnaires (n ¼ 148) administered to policy makers, conservation scientists, individuals representing non-government organizations (NGOs), and field officials, who implemented government policies and enforced laws. We found significant differences among attitudes of stakeholders identifying major threats to wildlife, the use of science, the role of poaching in conservation, and the composition of species illegally traded. Policy makers and field officials differed in their views with NGOs and scientists on community response to wildlife policies and the varying threat perceptions to different species due to poaching and illegal trade. We noted ambiguity among stakeholders about sustainable use principles in India. Policies must be more effective in conservation and the process of making policy must be broad-based and participatory if wildlife conservation is to advance on the subcontinent. ß 2011 The Wildlife Society.
The SARS-CoV-2 virus has spread worldwide to cause a full blown pandemic since 2020. To date, several promising synthetic therapeutics are repurposed and vaccines through different stages of clinical trials were approved and being administered, but still the efficacy of the drugs and vaccines are yet to be decoded. This article highlights the importance of traditional medicinal plants and the phytomolecules derived from them, which possess in vitro antiviral and anti-CoV properties and further explores their potential as inhibitors to molecular targets of SARS-CoV-2 that were evaluated by in silico approaches. Botanicals in traditional medicinal systems have been investigated for anti-SARS-CoV-2 activity through in silico and in vitro studies. However, information linking structure of phytomolecules to their antiviral activity is limited. Most phytomolecules with anti-CoV activity were studied for inhibition of the human ACE2 receptor through which the virus enters host cells, and non-structural proteins 3CL pro and PL pro . Although the proteases are ideal anti-CoV targets, information on plant-based inhibitors for the CoV structural proteins, e.g., spike, envelope, membrane, nucleocapsid required further investigations. In absence of scientific evaluations through in vitro and biocompatibility studies, plant-based antivirals fall short as treatment options. Plant-based anti-SARS-CoV-2 therapeutics can be promising alternatives to their synthetic counterparts as they are economical and bear fewer chances of toxicity, side effects, and viral resistance. Our review could provide a systematic overview of the potential phytomolecules which can be repurposed and subjected to further modes of experimental evaluation to qualify for use in treatment and prophylaxis of SARS-CoV-2 infections.
Ex situ conservation is one of the major ways to strengthen biodiversity conservation. In China, ex situ conservation institutions mainly include zoos, aquariums, and breeding centers. In 1996, China began to import living animals duty-free for conservation purposes. Here, we built a dataset of nearly 300 vertebrate species (mammals, birds, fish and reptiles) imported into China over this past 20 years by interviewing all 123 institutions importing animals duty-free during 1996–2015. We then analyzed the annual variation of the species composition and individual numbers of these imported species, and quantified the relative population growth rate of each imported species for the first time. We found that the number of living animals imported into China decreased significantly year by year. The number of imported bird species and reptile individuals decreased the most, but the population growth rate was increasing for about half of the imported threatened species. We recommend that conservation institutions should enhance communication and promote cooperative breeding among them. Scientific research and sustainability assessments of threatened species should also be enhanced, which will allocate trade licenses and quotas more effectively. We hope that the data presented in this paper will contribute to the development of conservation policies, leading to stronger management of these imported species in China.
In December 2019, an outbreak of severe acute respiratory syndrome Coronavirus (SARSCoV-2) infection occurred in Wuhan city, Hubei Province, China (East Asia) furthermore worldwide including India. On 30 January 2020, the first case of the COVID-19 pandemic was reported in India. India has reached more than 1.5 lakh confirmed cases including more than 4000 fatalities by dreadful COVID-19 infection. At present, there is no vaccine for prevention or medicine for treatment. Only preventive measures like frequently hand-wash by soap and water, or hand sanitizers along with social distancing are effective to avoid the exposure of this virus. Ayurveda is the oldest acknowledged organized medicine on the earth. Immunity has an important role in maintaining health and prevention of diseases. In Ayurveda, Rasayana drugs are known for their immunomodulation and rejuvenation properties. On March 31, 2020, Ministry of AYUSH has issued advisory for enhancing immunity through lifestyle modification, dietary management, prophylactic interventions and simple remedies based on the symptoms. After that successful implementation, Government of India has planned to conduct clinical trials on three herbal nootropic and immunomodulatory drugs viz. Ashwagandha, Guduchi and Mulethi and AYUSH-64 (Ayurvedic anti-malaria drug) for their preventive properties against Covid-19 infections. This review article covers summary of the COVID-19 i.e. transmission, clinical presentation, investigation and prevention along with preventive measures in according to Ayurveda that can be adopted for future clinical trial.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.